BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Genox Corporation

Genox is a biotechnological company dedicated to the development and application of non-invasive human Oxidative Stress Profiling techniques. These applications include: Sports Medicine

Medical Diagnostics

Basic Scientific Research

Natural Foods & Agricultural Produce

Nutrition & Diet Evaluation

Preventive Medical Strategies

Epidemiological Studies

Risk Assessment of Accelerated Aging

Individual Optimization of Health span


Contact Details:
1414 Key Highway
Baltimore
MD
21230
United States of America
Tel:410 347 7616
Fax:410 347 7617
Email:
WWW:

www.genox.com/




Loading...

Recent Publications by Genox Corporation:

The NR4A nuclear receptor family in eosinophils.
It is well-known that many members of the family of nuclear receptors have...
17th March, 2007
Genox Research Inc., Bunkyo, Tokyo, 112-8088, Japan. J Hum Genet. 2007;52(1):13-20. Epub 2006 Nov 10.
DOI Direct Link
Tenascin-C is upregulated in the skin lesions of patients with atopic dermatitis.
BACKGROUND: Tenascin-C is a large, hexameric extracellular matrix...
11th November, 2005
Genox Research Inc., Ibaraki, Laboratory of Seeds Finding Technology, J Dermatol Sci. 2005 Oct;40(1):35-41.
DOI Direct Link
Prostaglandin A2 acts as a transactivator for NOR1 (NR4A3) within the nuclear receptor superfamily.
Within the nuclear receptor superfamily, Nur77, Nurr1, and NOR1 constitute...
29th October, 2005
Genox Research Inc., Tokyo, Japan. Biol Pharm Bull. 2005 Sep;28(9):1603-7.
NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro.
To identify novel genes related to the clinical signs of atopic dermatitis...
2nd July, 2005
Genox Research Inc., Bunkyo, Japan. Int Arch Allergy Immunol. 2005;137 Suppl 1:35-44. Epub 2005 Jun 2.
DOI Direct Link
Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis.
BACKGROUND: Atopic dermatitis (AD) and psoriasis are common inflammatory...
29th April, 2005
Genox Research Inc., Ibaraki, Japan. J Dermatol Sci. 2004 Dec;36(3):157-64.
DOI Direct Link

View more Genox Corporation research publications.

Genox Corporation Patents:

US Patent No.Title
7172867 Methods of testing for allergic diseases, and therapeutic agents for treating same
7160683 Method of testing for bronchial asthma
7148011 Method of testing for allergic diseases
7115373 Method of testing for atopic dermatitis by measuring expression of the NOR-1 gene
6986990 Pollen allergy-related gene 513

View more Genox Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 215 times since April 2007, the link to the organisation's website has been followed 54 times

Recent Search Terms used to find this page: Genox Corporation | Genox corporation | genox corporation | Genox Corporation | www.genox.com | genox | genox research inc | genox corporation | www.genox.com | genox direct | .

Search for more companies in Baltimore

Search for more companies in MD



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Genox Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.